Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BTG USA licenses transvenous lead:

This article was originally published in Clinica

Executive Summary

BTG USA says it has licensed a transvenous pacing lead to an unnamed cardiac company. The device, invented by Dr Leo Rubin of Suffern, New York, uses a helical wire to anchor the electrode near the His bundle. A second version uses retractable barbs. BTG USA, which is part of UK-based British Technology Group, acquired rights to the lead in 1992. It is patented in the US and the organisation is pursuing patent protection internationally. BTG would not name the purchaser but says it is a major supplier of cardiac care products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091875

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel